ACE Report Cover
Periarticular Multidrug Injection versus Epidural Catheter in Total Hip Arthroplasty
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
Periarticular Multidrug Injection versus Epidural Catheter in Total Hip Arthroplasty .

Comparison of periarticular multidrug injection versus epidural catheter in 55 patients undergoing total hip arthroplasty: A prospective randomized controlled trial

Orthop Traumatol Surg Res . 2022 Feb;108(1):103094. doi: 10.1016/j.otsr.2021.103094.
Contributing Authors

T Ukai G Ebihara M Watanabe

Fifty-five patients undergoing primary total hip arthroplasty were randomized to receive a periarticular multidrug injection (PMDI, n=28) or an epidural catheter (n=27) for postoperative pain control. The primary outcomes of interest were pain scores, narcotic consumption, function, inflammatory markers and complications. There were no differences in pain scores or narcotic consumption in the postoperative period between groups. The PMDI group had greater range of motion on postoperative day 3 and were more successful in performing a straight leg raise on postoperative day 1. However, no differences in range of motion in postoperative days 1 or 2 were found. The PMDI group was found to have significantly lower inflammatory markers in the immediate postoperative period when compared to the epidural catheter group.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Periarticular Multidrug Injection versus Epidural Catheter in Total Hip Arthroplasty. ACE Report. 2022;220(2):1. Available from: https://myorthoevidence.com/AceReport/Show/periarticular-multidrug-injection-versus-epidural-catheter-in-total-hip-arthroplasty

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report